Physica Pharma has established strategic partnerships with industrial and academic organizations.
Scientific and Marketing partnership with Seppic, a subsidiary of "l'Air Liquide" Group, for the supply of original delivery agents used in our bioavailability enhancement technology. Seppic collaborates with Physica Pharma and synthesizes these delivery agents exclusively for Physica Pharma drug delivery systems.
Strategic partnership with Markos-Mefar, a subsidiary of "l'Air Liquide" Group specialised in nasal delivery device. Physica Pharma and Markos Mefar collaborate for the development of an intranasal Somatropine.
Scientific partnership with the INSTITUT DE PHARMACOLOGIE MOLECULAIRE ET CELLULAIRE (IPMC) based in Sophia-Antipolis Science Park. IPMC is an academic research centre affiliated to the French National Centre for Scientific Research (CNRS) and the University of Nice. Physica Pharma collaborates with IPMC for the development of in vitro models of cell systems used to simulate drug transport across biological barriers.
